Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Radich

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Blood|April 1, 1997
Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantationJ Radich, G Gehly, A Lee, et al.
Bone Marrow Transplantation|July 23, 1998
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex systemS D Rowley, M Loken, J Radich, et al.
Leukemia|July 31, 2009
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive valueA Hochhaus, M C Müller, J Radich, et al.
The New England Journal of Medicine|April 2, 1998
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemiaJ A Hansen, T A Gooley, P J Martin, et al.
Blood|August 15, 1997
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaJ Sierra, J Radich, J A Hansen, et al.
Leukemia|November 13, 2008
BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting featuresN C P Cross, G Q Daley, A R Green, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effectL Feinstein, B Sandmaier, D Maloney, et al.
Blood|May 23, 2001
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsP A McSweeney, D Niederwieser, J A Shizuru, et al.
Blood|April 15, 1997
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantationJ T Slattery, R A Clift, C D Buckner, et al.
Physical Review Letters|May 14, 2016
High-Precision Half-Life Measurements for the Superallowed β^{+} Emitter ^{10}C: Implications for Weak Scalar CurrentsM R Dunlop, C E Svensson, G C Ball, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Blood|April 1, 1997
Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantationJ Radich, G Gehly, A Lee, et al.
Bone Marrow Transplantation|July 23, 1998
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex systemS D Rowley, M Loken, J Radich, et al.
Leukemia|July 31, 2009
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive valueA Hochhaus, M C Müller, J Radich, et al.
The New England Journal of Medicine|April 2, 1998
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemiaJ A Hansen, T A Gooley, P J Martin, et al.
Blood|August 15, 1997
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemiaJ Sierra, J Radich, J A Hansen, et al.
Leukemia|November 13, 2008
BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting featuresN C P Cross, G Q Daley, A R Green, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effectL Feinstein, B Sandmaier, D Maloney, et al.
Blood|May 23, 2001
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsP A McSweeney, D Niederwieser, J A Shizuru, et al.
Blood|April 15, 1997
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantationJ T Slattery, R A Clift, C D Buckner, et al.
Physical Review Letters|May 14, 2016
High-Precision Half-Life Measurements for the Superallowed β^{+} Emitter ^{10}C: Implications for Weak Scalar CurrentsM R Dunlop, C E Svensson, G C Ball, et al.
Pageof 5